Andrew Cheng > Goodwin > Santa Monica, United States > Lawyer Profile
Goodwin Offices
520 Broadway Suite #500
Santa Monica
CA 90401
CALIFORNIA
United States
- Firm Profile
- Go to...
Andrew Cheng
Position
Partner
Career
Andrew W. Cheng is a partner in Goodwin’s Private Equity group and a member of the firm’s Debt Finance practice. Mr. Cheng’s practice focuses on representing borrowers, private equity sponsors, financing providers and lenders in acquisition financings, pharmaceutical financings and other complex leveraged finance transactions, in both the non-distressed and distressed contexts.
Education
JD, 2000, Harvard Law School / BA, 1997, Amherst College (magna cum laude)
Lawyer Rankings
United States > Finance > Commercial lending
The debt finance practice at Goodwin bolsters expertise in the representation of both lenders and borrowers, though it is particularly noted for its work on middle market transactions in the technology, healthcare and life sciences sectors from a borrower-side perspective. Key areas of work include acquisition financing, venture financing relating to emerging companies, and multi-tranche financing for financial sponsors. Jennifer Bralower spearheads the offering from New York, focused on syndicated credit facilities and junior capital, closely backed by Kristopher Ring and Anna Dodson, working out of the Santa Monica and Boston offices, respectively. Andrew Cheng joined the Santa Monica office from Gibson, Dunn & Crutcher LLP in June 2022, a move to strengthen the firm’s borrower-side capabilities.
Lawyer Rankings
Top Tier Firm Rankings
- Finance > Financial services regulation
- Industry focus > Cannabis
- Intellectual property > Patents: licensing
- Real estate > Real estate investment trusts (REITs)
- Media, technology and telecoms > Technology transactions
- M&A/corporate and commercial > Venture capital and emerging companies
Firm Rankings
- Finance > Capital markets: equity offerings
- Industry focus > Education
- Labor and employment > ERISA litigation
- Finance > Fintech
- Healthcare > Life sciences
- Dispute resolution > M&A litigation: defense
- M&A/corporate and commercial > M&A: middle-market ($500m-999m)
- Investment fund formation and management > Mutual/registered/exchange-traded funds
- Dispute resolution > Securities litigation: defense
- Finance > Capital markets: debt offerings
- International Trade > CFIUS
- M&A/corporate and commercial > Corporate governance
- Media, technology and telecoms > Cyber law (including data privacy and data protection)
- Dispute resolution > E-discovery
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Dispute resolution > Financial services litigation
- Antitrust > Merger control
- Intellectual property > Patents: litigation (full coverage)
- Investment fund formation and management > Private equity funds (including venture capital)
- Dispute resolution > Product liability, mass tort and class action - defense: consumer products (including tobacco)
- Real estate > Real estate
- M&A/corporate and commercial > Shareholder activism
- Intellectual property > Trade secrets (litigation and non-contentious matters)
- Tax > US taxes: non-contentious
- Labor and employment > Workplace and employment counseling
- Labor and employment > Employee benefits, executive compensation and retirement plans: design
- Dispute resolution > Leading trial lawyers
- M&A/corporate and commercial > Private equity buyouts: large deals ($500m+)
- Healthcare > Service providers
- International Trade > Customs, export controls and economic sanctions
- Dispute resolution > Leading trial lawyers
- Finance > Restructuring (including bankruptcy): corporate
- Dispute resolution > Appellate: courts of appeals / Appellate: supreme courts (states and federal)
- Finance > Commercial lending
- Dispute resolution > Corporate investigations and white-collar criminal defense
- Intellectual property > Patents: prosecution (including re-examination and post-grant proceedings)